Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 52(9): e8935, 2019. graf
Article Dans Anglais | LILACS | ID: biblio-1019568

Résumé

The scientific publication landscape is changing quickly, with an enormous increase in options and models. Articles can be published in a complex variety of journals that differ in their presentation format (online-only or in-print), editorial organizations that maintain them (commercial and/or society-based), editorial handling (academic or professional editors), editorial board composition (academic or professional), payment options to cover editorial costs (open access or pay-to-read), indexation, visibility, branding, and other aspects. Additionally, online submissions of non-revised versions of manuscripts prior to seeking publication in a peer-reviewed journal (a practice known as pre-printing) are a growing trend in biological sciences. In this changing landscape, researchers in biochemistry and molecular biology must re-think their priorities in terms of scientific output dissemination. The evaluation processes and institutional funding for scientific publications should also be revised accordingly. This article presents the results of discussions within the Department of Biochemistry, University of São Paulo, on this subject.


Sujets)
Humains , Périodiques comme sujet/statistiques et données numériques , Édition/tendances , Recherche , Biochimie , Biologie moléculaire , Périodiques comme sujet/normes , Périodiques comme sujet/tendances , Brésil
2.
Braz. j. med. biol. res ; 33(10): 1133-40, Oct. 2000. ilus
Article Dans Anglais | LILACS | ID: lil-270216

Résumé

This article reviews recent results of studies aiming to elucidate modes of integrating signals initiated in ACTH receptors and FGF2 receptors, within the network system of signal transduction found in Y1 adrenocortical cells. These modes of signal integration should be central to the mechanisms underlying the regulation of the G0->G1->S transition in the adrenal cell cycle. FGF2 elicits a strong mitogenic response in G0/G1-arrested Y1 adrenocortical cells, that includes a) rapid and transient activation of extracellular signal-regulated kinases-mitogen-activated protein kinases (ERK-MAPK) (2 to 10 min), b) transcription activation of c-fos, c-jun and c-myc genes (10 to 30 min), c) induction of c-Fos and c-Myc proteins by 1 h and cyclin D1 protein by 5 h, and d) onset of DNA synthesis stimulation within 8 h. ACTH, itself a weak mitogen, interacts with FGF2 in a complex manner, blocking the FGF2 mitogenic response during the early and middle G1 phase, keeping ERK-MAPK activation and c-Fos and cyclin D1 induction at maximal levels, but post-transcriptionally inhibiting c-Myc expression. c-Fos and c-Jun proteins are mediators in both the strong and the weak mitogenic responses respectively triggered by FGF2 and ACTH. Induction of c-Fos and stimulation of DNA synthesis by ACTH are independent of PKA and are inhibited by the PKC inhibitor GF109203X. In addition, ACTH is a poor activator of ERK-MAPK, but c-Fos induction and DNA synthesis stimulation by ACTH are strongly inhibited by the inhibitor of MEK1 PD98059.


Sujets)
Humains , Animaux , Cortex surrénal/cytologie , Récepteur corticotrophine/physiologie , Transduction du signal/physiologie , Tumeurs corticosurrénaliennes , Cycle cellulaire/physiologie , Mitogen-Activated Protein Kinase Kinases/métabolisme , Protéine kinase C/métabolisme , Récepteur facteur croissance fibroblaste/physiologie , Cellules cancéreuses en culture/physiologie
3.
Braz. j. med. biol. res ; 32(7): 841-3, July 1999.
Article Dans Anglais | LILACS | ID: lil-234889

Résumé

FGF2 elicits a strong mitogenic response in the mouse Y-1 adrenocortical tumor cell line, that includes a rapid and transient activation of the ERK-MAPK cascade and induction of the c-Fos protein. ACTH, itself a very weak mitogen, blocks the mitogenic response effect of FGF2 in the early and middle G1 phase, keeping both ERK-MAPK activation and c-Fos induction at maximal levels. Probing the mitogenic response of Y-1 cells to FGF2 with ACTH is likely to uncover reactions underlying the effects of this hormone on adrenocortical cell growth


Sujets)
Animaux , Souris , Tumeurs corticosurrénaliennes , Hormone corticotrope/pharmacologie , Mitogen-Activated Protein Kinase 1/pharmacologie , Protéines proto-oncogènes c-fos/pharmacologie , Récepteur facteur croissance fibroblaste/effets des médicaments et des substances chimiques , Transformation cellulaire néoplasique/effets des médicaments et des substances chimiques , Interactions médicamenteuses
4.
Braz. j. med. biol. res ; 29(3): 343-5, Mar. 1996. tab, graf
Article Dans Anglais | LILACS | ID: lil-163841

Résumé

Adrenocorticotropic hormone (ACTH) triggers well-defined responses in Y-1 cells. Among them is steroidogenesis stimulation. We have previously shown that phorbol 12-myristate 13-acetate (PMA), an activator of the calcium- and phospholipid-dependent protein kinase (PKC) is able to mimic all the responses triggered by ACTH in these cells, including steroidogenesis stimulation. Short (2 h) treatment with PMA leads to only 20-30 per cent of the maximal steroidogenesis stimulation obtained with ACTH. However, the steroid secretion in the 2 h that follows the short-term (2 h) PMA treatment reaches the same levels as observed with ACTH, i.e., a 12- to 15-fold increase. We also show that this effect is restricted to cells treated with PMA for up to 4 h, while treatment for longer periods of time causes a reduction of the steroid biosynthesis rate, an effect that is not observed in cells treated with ACTH or N6,2'-O-dibutyryladenosine 3',5'-cyclic monophosphate (dcAMP). These results suggest that activation of PKC can elicit the first phase of ACTH steroidogenesis stimulation, but not the second one, which strictly depends on activation of cAMP-dependent protein kinase.


Sujets)
Hormone corticotrope/métabolisme , AMP cyclique/métabolisme , Esters de phorbol/métabolisme , Stéroïdes/biosynthèse , Hormone corticotrope/physiologie
7.
Braz. j. med. biol. res ; 21(6): 1155-61, 1988. tab
Article Dans Anglais | LILACS | ID: lil-65012

Résumé

1. Peptide growth factors and products of some oncogenes are likely to be active in common regulatory pathways that control the cell cycle. 2. Cell transformation by DNA -mediated transfections with cloned oncogenes is an approach that can provide insight into the mechanisms of both growth factor action and cell cycle regulation. 3. This paper deals with this approach, summarizing and discussing transfection experiments of mouse c-myc- and human c-Ha-ras-1 cloned oncogenes into mouse embryo Balb-3T3 cells


Sujets)
Structures de l'embryon/cytologie , Substances de croissance/pharmacologie , Oncogènes , Transformation cellulaire néoplasique , ADN tumoral
SÉLECTION CITATIONS
Détails de la recherche